China Hyaluronic Acid Market Size & Outlook, 2026-2033
The hyaluronic acid market in China is expected to reach a projected revenue of US$ 1,368.0 million by 2033. A compound annual growth rate of 10.1% is expected of China hyaluronic acid market from 2026 to 2033.
Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology
Other key industry trends
In terms of revenue, China accounted for 5.5% of the global hyaluronic acid market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China hyaluronic acid market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 507.3 million by 2033.
China is the most populated country around the world with a large geriatric population. According to United Nations, the population in China in 2019 was about 1.4 billion, and the population aged 65 and above accounts for about 11.5% (i.e., 164.5 million).
As per “Patient-centered-New Insights on Bone and Joint Health Management" report, the total number of osteoarthritis patients in China reached 61.2 million in 2017. Furthermore, the statistics of the country’s Health Organization suggests that the incidence of cataract in China among the elderly population aged 60 to 89 is as high as 80% and that in people over 90 years is 90%.
China has the third highest number of cosmetic surgeons after the U.S. and Brazil. Over 3,000 cosmetic surgeons were present in China in 2020, as per ISAPS estimates. The country is among the top three most-cited countries by foreign patients for cosmetic procedures.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Hyaluronic Acid Market Outlook will help companies and investors design strategic landscapes.
Dermal Fillers was the largest segment with a revenue share of 56.87% in 2025.
Horizon Databook has segmented the China hyaluronic acid market based on dermal fillers, vesicoureteral reflux, osteoarthritis, ophthalmic covering the revenue growth of each sub-segment from 2021 to 2033.
China is the most populated country around the world with a large geriatric population. According to United Nations, the population in China in 2019 was about 1.4 billion, and the population aged 65 and above accounts for about 11.5% (i.e., 164.5 million).
As per “Patient-centered-New Insights on Bone and Joint Health Management" report, the total number of osteoarthritis patients in China reached 61.2 million in 2017. Furthermore, the statistics of the country’s Health Organization suggests that the incidence of cataract in China among the elderly population aged 60 to 89 is as high as 80% and that in people over 90 years is 90%.
China has the third highest number of cosmetic surgeons after the U.S. and Brazil. Over 3,000 cosmetic surgeons were present in China in 2020, as per ISAPS estimates. The country is among the top three most-cited countries by foreign patients for cosmetic procedures.
China Hyaluronic Acid Market Application Outlook (Revenue, USD Million , 2021-2033)
Dermal Fillers
Osteoarthritis
Ophthalmic
Vesicoureteral Reflux
Reasons to subscribe to Hyaluronic Acid Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Hyaluronic Acid Market Outlook databook
Our clientele includes a mix of Hyaluronic Acid Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Hyaluronic Acid Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Hyaluronic Acid Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.